Not logged in Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial Shore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Stage-standardized and stage-specific survival among men with prostate cancer in the Nordic countries 2004-16: the NORDCAN survival studies Larsen, Signe Benzon; Lundberg, Frida E.; Friis, Soren; Birgisson, Helgi; Andersson, Therese M. L.; Engholm, Gerda; Lambert, Paul C.; Brasso, Klaus; Pettersson, David; Olafsdottir, Elinborg; Johannesen, Tom Borge; Konig, Simon M.; Johansson, Anna L., V; Morch, Lina Steinrud Share Save
The risk of new-onset type 2 diabetes and the influence of risk factors among men with prostate cancer in the Danish Diet, Cancer, and Health study Widding, Jeppe Lyngbye; Barsoe, Monika; Ammitzboll, Gunn; Dalton, Susanne Oksbjerg; Olsen, Maja Halgren; Levinsen, Anne Katrine Graudal; Brasso, Klaus; Laurberg, Tinne Share Save
Prescription patterns demonstrate high demand for treating erectile dysfunction following radical prostatectomy Larsen, SB; von Heymann, A; Stroomberg, H; Friberg, AS; Brasso, K; Roder, A; Dalton, SO; Karlsen, R; Bidstrup, PE; Giraldi, A; Johansen, C Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047) Parker, C. C.; Petersen, P. M.; Cook, A. D.; Clarke, N. W.; Catton, C.; Cross, W. R.; Kynaston, H.; Parulekar, W. R.; Persad, R. A.; Saad, F.; Bower, L.; Durkan, G. C.; Logue, J.; Maniatis, C.; Noor, D.; Payne, H.; Anderson, J.; Bahl, A. K.; Bashir, F.; Bottomley, D. M.; Brasso, K.; Capaldi, L.; Chung, C.; Cooke, P. W.; Donohue, J. F.; Eddy, B.; Heath, C. M.; Henderson, A.; Henry, A.; Jaganathan, R.; Jakobsen, H.; James, N. D.; Joseph, J.; Lees, K.; Lester, J.; Lindberg, H.; Makar, A.; Morris, S. L.; Oommen, N.; Ostler, P.; Owen, L.; Patel, P.; Pope, A.; Popert, R.; Raman, R.; Ramani, V.; Roder, A.; Sayers, I.; Simms, M.; Srinivasan, V.; Sundaram, S.; Tarver, K. L.; Tran, A.; Wells, P.; Wilson, J.; Zarkar, A. M.; Parmar, M. K. B.; Sydes, M. R. Share Save
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P) Loffeler, Sven; Bertilsson, Helena; Mueller, Christoph; Aas, Kirsti; Haugnes, Hege Sagstuen; Aksnessaether, Bjorg; Pesonen, Maiju; Thon, Kristian; Tandstad, Torgrim; Murtola, Teemu; Poulsen, Mads Hvid; Nordstrom, Tobias; Vigmostad, Maria Nyre; Ottosson, Fredrik; Holmsten, Karin; Christiansen, Ola; Slaaen, Marit; Haug, Erik Skaaheim; Storas, Anne Holck; Asphaug, Lars; Rannikko, Antti; Brasso, Klaus Share Save
Treatment (tx) of high-risk biochemically recurrent prostate cancer with enzalutamide (enza) in combination with leuprolide acetate (LA): Secondary endpoints from EMBARK Freedland, S. J.; Gleave, M. E.; De Giorgi, U. F. F.; Rannikko, A.; Pieczonka, C.; Sridharan, S.; Brasso, K.; Woo, H.; Caamano, A. Gomez; Saranchuk, J.; Nordquist, L. T.; Ferreira, U.; Tang, Y.; Rosbrook, B.; Haas, G. P.; Rosales, M.; Zohren, F.; Shore, N. D. Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
